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EDITORIAL 
 
Biological aspects of bone, cartilage and tendon regeneration 
Marko Pecina and Slobodan Vukicevic 
 
Current orthopedic procedures in supporting regeneration of bone, cartilage and tendon are 
dependant on our understanding of the molecular processes responsible for tissue repair. At 
present we know how to regenerate bone when physiological mechanisms of fracture repair 
fail [13]. Since the original description of the potential of demineralized bone matrix to induce 
bone at an ectopic site it took more than three decades to bring bone morphogenetic proteins 
(BMPs) to clinical use. By the end of 2007 nearly one million patients worldwide will be 
treated with BMPs for spinal fusions, non-unions, acute fractures and maxillofacial 
reconstruction. Use of animal models, genomics and proteomics deciphered new mechanisms 
and candidate molecules for the regeneration of joint cartilage and tendons, opening new 
avenues in regenerative orthopedics.  
This special volume reviews novel strategies in the regeneration of bone, cartilage and tendon. 
Bishop and Einhorn [2] describe the clinical use of recombinant BMP-2 and BMP-7. They 
predict that current techniques in engineering bone for restoring defined skeletal defects 
represent a unique opportunity for BMPs in the future. McKay and colleagues [9] reviewed 
the clinical applications of BMP-2 (INFUSE Bone Graft), while Vaccaro, McKee and 
colleagues [14] describe the clinical applications of BMP-7 (OP-1 implant or Osigraft). 
Authors suggest that recombinant human BMP based devices, when properly applied, can 
eliminate the need to harvest autologous bone for grafting procedures benefiting both the 
surgeon and patients. Grgurevic and collaborators [6] describe molecules discovered by 
proteomic analysis in the plasma of patients with an acute bone fracture. The characterization 
and use of potential new biomarkers, like TGF-β induced protein IG-H3, cartilage acidic 
protein 1, procollagen C proteinase enhancer protein and TGF-β receptor III, for bone and 
cartilage regeneration are discussed. Sendak and colleagues [11] review the newly discovered 
role of thyroid stimulating hormone (TSH) and follicle stimulating hormone (FSH) in bone 
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remodeling. It has been recently found that low doses of TSH increase bone volume and 
improve bone microarchitecture and strength in aged osteoporotic rats, suggesting TSH 
directly affects bone remodeling in vivo [10]. Grasser and collaborators [5], by using a 
genomic approach, deciphered the potential mechanism of bone augmentation following 
systemic administration of BMP-6, suggesting that IGF-1 and EGF mediate, at least in part, 
the effects of BMP-6 on bone, which has been recently reported [12]. The role of 
prostaglandin E2 receptors and their analogs in bone formation is reviewed by Li and 
colleagues [8] demonstrating that the PGE2 receptor is essential for restoring bone defects in 
animal models. Cartilage regeneration and chronic back pain due to degenerative disc disease 
are among major obstacles in orthopedics. Chubinskaya and colleagues [4] summarized the 
role of osteogenic protein-1 (BMP-7) in animal models of osteochondral and chondral defects, 
osteoarthritis and degeneration in intervertebral disc cartilage. They show that OP-1 is 
exhibiting unique pro-anabolic and prominent anti-catabolic properties having a potential for 
treating cartilage and disc lesions.  
Overuse tendon disorders are common and related to a significant morbidity. Tendon and 
ligament function engineering and repair are discussed in articles by Aspenberg [1] and by 
Hoffman and Gross [7]. Aspenberg found that the repair of subcutaneous tendon ruptures can 
be stimulated by a single application of one of several growth factors, including PDGF, TGF-
β, IGF-1, VEGF and GDF-5,-6,-7, or by a thrombocite concentrate. The response is 
dependent on the mechanical microenvironment, which is crucial for the repair process.  
Hoffmann and Gross specifically discuss gene-therapeutic approaches using mesenchymal 
stem cells for a potential future application in tendon/ligament regeneration. 
Borovecki and colleagues [3] discuss the potential of a genomic approach in analyzing bone 
homeostasis and diseases. Gene expression profiling studies yielded novel insights into the 
complex interplay of osteoblast and osteoclast regulation, paracrine and endocrine control of 
bone and cartilage remodeling, as well as the pathophysiology of osteoporosis and bone 
tumors.  
We believe that this volume will provide basic and clinical scientists with the state of art in 
regenerative orthopedics.  
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